14.12.2016 18:12:00

Research and Markets - Diabetes Diagnostics 2015-2022: Global Strategic Business Report 2016 - Diabetes Diagnostics Innovations & Advancements / Recent Industry Activity / Market Trends, Issues &...

DUBLIN, Dec 14, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Diabetes Diagnostics - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments:

  • Continuous Glucose Monitoring (CGM) Systems
  • HbA1c Testing Devices
  • Blood Glucose Monitoring Devices

The report profiles 58 companies including many key and niche players such as

  • Abbott Diabetes Care, Inc. (US)
  • Acon Laboratories, Inc. (US)
  • AgaMatrix, Inc. (US)
  • Alere Inc. (US)
  • Animas Corporation (US)
  • Apex Biotechnology Corporation (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • A.Menarini Diagnostics Ltd. (UK)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (US)
  • Bayer Healthcare Diabetes Care (US)
  • Beckman Coulter, Inc. (US)
  • Bio-Rad Laboratories (US)
  • BIONIME Corporation (Taiwan)
  • Diazyme Laboratories Inc. (US)
  • Dexcom, Inc. (US)
  • EKF Diagnostics Holdings Plc (UK)
  • HemoCue® AB (Sweden)
  • Infopia Co., Ltd. (South Korea)
  • LifeScan, Inc. (US)
  • Medtronic MiniMed, Inc. (US)
  • Nova Biomedical Corporation (US)
  • PTS Diagnostics (US)
  • Roche Diagnostics (Switzerland)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Siemens Healthineers (Germany)
  • Taidoc Technology Corporation (Taiwan)
  • Tandem Diabetes Care, Inc. (US)
  • Terumo Corporation (Japan)
  • Tosoh Bioscience, Inc. (US)
  • Trinity Biotech plc (Ireland)
  • Trividia Health, Inc. (US)
  • Ypsomed AG (Switzerland)

Key Topics Covered:

1. Industry Overview

2. Competition

3. Market Trends, Issues & Drivers

4. Diabetes Diagnostics Innovations & Advancements

5. Product Overview

6. Product Launches

7. Recent Industry Activity

8. Focus On Select Global Players

9. Global Market Perspective

Total Companies Profiled: 58 (including Divisions/Subsidiaries 75)

  • The United States (35)
  • Canada (1)
  • Japan (4)
  • Europe (23)
  • - France (2)
  • - Germany (4)
  • - The United Kingdom (8)
  • - Italy (1)
  • - Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (10)
  • Middle-East (2)

For more information about this report visit http://www.researchandmarkets.com/research/8gkx7t/diabetes

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Nachrichten zu EpiCept Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu EpiCept Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!